Mixed cryoglobulinaemia a guide to drug treatment

Clinical Immunotherapeutics

Volumn 5, Issue 2, 1996, Pages 115-121

  Misiani, Rocco ^a   Bellavita, Piermario ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; HEPATITIS C ANTIBODY;

B LYMPHOCYTE; CRYOGLOBULINEMIA; HEPATITIS C; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW;

EID: 0030055842     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259318     Document Type: Article

References (49)

1. Gorevic PD, Kassab HJ, Levo Y, el al. Mixed cryoglobulinemia: clinical aspects and long term follow-up of 40 patients. Am J Med 1980:69:287-308
2. Gaddy CG, Powell LW. Raynaud's syndrome associated with cryoglobulinemia and cold-agglutinins. Arch Intern Med 1958; 102:468-73
3. Costanzi JJ, Coltman CA, Clark DA, et al. Cryoglobulinemia associated with macroglobulin. Studies of a 17.5 S cryoprecipitating factor. Am J Med 1965; 39: 163-8
4. MacKay JR, Eriksen N, Motulsky AG, et al. Cryo and macroglobulinemia. Am J Med 1956; 20: 564-9
5. Cream JJ. Immunofluorescent studies of the skin in cryoglobulinemic vasculitis. Br J Dermatol 1971; 84: 48-53
6. Sinico RA, Winearls CG, Sabbadini E, et al. Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis. Kidney Int 1988; 34: 109-16
7. Mclntosh RM, Grinswold WR, Chernack WB. et al. Cryoglobulins. III. Further studies on the nature, incidence, clinical, diagnostic, prognostic and immunopathologic significance of cryoglobulins in renal disease. Q J Med 1975; 44: 285-307
8. Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974:57:775-88
9. Tarantino A, De Vecchi A, Montagnino G, et al. Renal disease in essential mixed cryoglobulinemia. Long-term follow-up of 44 patients. Q J Med 1981 ; 50: 1-30
10. Frankel AH, Singer DRJ, Winearls CO, et al. Type II essential mixed cryoglobulinemia: presentation, treatment and outcome in 13 patients. Q J Med 1992; 298: 101-24
11. Levo Y, Gorevich P, Kassab HJ, et al. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977:296: 1501-4
12. Popp Jr JW. Dienstag JL, Wands JR. et al. Essential mixed cryoglobulinemia without evidenee tor hepatitis B virus infection. Ann Intern Med 1980; 92: 379-83
13. Fiorini G. Sinieo RA. Winearls CO. et al. Persistent EpsteinBarr virus infection in patients with type II essential mixed eryoglobulinemia. Clin Immunol Immunopathol 1988: 47: 262-9
14. Monteverde A. Rivano MT. Allegra GC. et al. Essential mixed eryoglobulinemia type II: a manifestation of low-grade malignant lymphoma? Acta Haematol 1988: 79: 20-5
15. Ferri C. Greco F, Longobardo G. et al. Association between hepatitis C virus and mixed eryoglobulinemia. Clin Exp Rheumatol 1991:9: 621-4
16. Misiani R. Bellavita R Fenili D, et al. Hepatitis C virus infection in patients with essential mixed eryoglobulinemia. Ann Intern Med 1992; 117:573-7
17. Agnello V, Chung RT. Kaplan LM. A role for hepatitis C virus infection in type II eryoglobulinemia. N Engl J Med 1992; 327: 1490-5
18. Misiani R. Vicari O, Bellavita P. etal. Hepatitis C virus in renal tissue of patients with glomerulonephritis. Nephron 1994; 68: 400
19. Sansonno D, Cornacchiulo V. lacobelli AR. et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed eryoglobulinemia. Hepatology 1995: 21: 305-12
20. Perl A, Gorevieh PD, Ryan DH. et al. Clonal B cell expansions in patients with essential mixed eryoglobulinemia. Clin Exp Immunol 1989:76: 54-60
21. Gabrielli A. Manzin A. Candela M. et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol 1994; 97: 87-93
22. Bonomo L. Casato M. Afeltra A, et al. Treatment of idiopathic mixed eryoglobulinemia with alpha Interferon. Am J Med 1987:83: 726-30
23. Misiani R. Bellavitu P. Fenili D. et al. Interferon alfa-2a therapy in eryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751 6
24. Johnson RJ. Gretch DR. Couser WG. et al. Hepatitis C virusassociated glomerulonephritis. Effect of ct-interferon therapy. Kidney Int 1994:46: 1700-4
25. Dammacco F. Sansonno D. Han JH. et al. Natural interferon-d versus its combination with 6-methyl-prednisolone in the therapy of type II mixed eryoglobulinemia: a long-term, randomized, controlled study. Blood 1994; 84: 3336-43
26. Piazza M. Orlando R. Tosone G. et al. Treatment of chronic hepatitis C with recombinant Interferon alfa-2b. Gut 1993: 34: 128-9
27. Kasahara A. Hayashi N. Hiraniatsu N. et al. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995; 21: 291-7
28. Poynard T, Bedossa P. Chevallier M. et al. A comparison of three interferon alfa-2h regimens for the long-term treatment of chronic non-A. non-B hepatitis. N Engl J Med 1995; 332: 1457-62
29. Misiani R. Type II eryoglobulinemia: therapeutic role of ainterferon. In: F.ible MM. Huber C, Peter HH, et al., editors. Symposium in immunology V. Antiviral immunity. Berlin: Springer Verlag. In press
30. Brillant! S, Carson J. Foli M. et al. Apilot study of combination therapy with ribavirin plus interferon alfa for interferon altaresistant chronic hepatitis C. Gastroenterology 1994; 107: 812-7
31. FeiJ.i T, Gitlin N. Immune-complex disease o (the kidney associated with chronic hepatitis and cryoglobulinemia. Lancet 1969;ii: 873-8
32. Mathison DA. Condemi JJ, Leddi JP, et al. Purpura, arthralgia and IgM-IgG cryoglobulinemia with rheumatoid factor activity. Ann Intern Med 1971; 74: 383-90
33. Skrifvars B, Tallqvist G, Törnöth T. Renal involvement in essential cryoglobulinemia. ActaMed Scand 1973; 194:229-34
34. Fong TL, Valinluck B. Govidarajan S, et al. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-9
35. De Vecchi A. Montagnino G, Tarantino A. et al. Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinaemia nephropathy. Clin Nephrol 1983; 19: 221-7
36. Clements PJ, Davis J. Cytotoxic drugs: their clinical application to rheumatic diseases. Semin Arthritis Rheum 1986; 15: 231-8
37. Geltner D. Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopathol 1988; 10: 103-11
38. Invernizzi F, Monti G. Colchicine and mixed cryoglobulinemia. Arthritis Rheum 1993: 36: 722-3
39. Boom BW, Brand A, Bowes Bavinck JN. et al. Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose y-globulin intravenously. Arch Dermatol 1988; 124: 1550-3
40. Jayne DRW, Davies MJ, Fox CJV, et al. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991:337: 1137-9
41. Stewart RRC, Winney RJ, Cash JD. Renal toxicity of intravenous immunoglobulins. Vox Sang 1993; 65: 244
42. Berkmann EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 1980; 20: 171-8
43. Geltner D, Kohn RW. Gorevich P, et al. The effect of combination therapy (steroids, immunosuppressives and plasmapheresis) on 5 mixed cryoglobulinaemia patients with renal, neurological and vascular involvement. Arthritis Rheum 1981:24: 1121-7
44. Pusey CD. Schifferly JA. Lockwood CM. et al. Use of plasma exchange in the management of mixed essential cryoglobulinemia. Artif Organs 1981; 5: 183-7
45. Ferri C, Moriconi L, Gremignai G, et al. Treatment of renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 1986: 43: 246-53
46. L'Abbate A, Paciucci A. Bartolomeo F. et al. Selective removal of plasma cryoglobulins in cryoglobulinemia. Proc Eur Dial Transplant Assoc 1977; 14: 486-94
47. McLeod BC. Sassetti RS. Plasmapheresis with return of cryoglobulin depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia. Blood 1980; 55: 866-70
48. Lockwood CM. Worlledge S. Nicholas A, et ai. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979; 300: 524-30
49. Grey HM. Kohler PF. Cryoglobulins. Semin Haematol 1973; 10: 87-112